Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Ann Rheum Dis. 2006 Jul;65(7):841-4. doi: 10.1136/ard.2005.048900.

Abstract

It remains to be seen whether rituximab can live up to the high expectations and offer a more effective treatment for patients with AASV

Publication types

  • Editorial
  • Review

MeSH terms

  • Antibodies, Antineutrophil Cytoplasmic / immunology*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • B-Lymphocytes / immunology
  • Humans
  • Immunologic Factors / therapeutic use*
  • Lymphocyte Depletion
  • Remission Induction
  • Rituximab
  • Vasculitis / drug therapy*
  • Vasculitis / immunology*

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab